AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care
1 other identifier
interventional
450
0 countries
N/A
Brief Summary
The study team proposes ATLAS (AI-Assisted TelerehabiLitAtion System) a two-part solution. The first-Rebee AI-assisted telerehabilitation device-assists in inpatient rehabilitation, and allows patients to continue with their physical rehabilitation when discharged and waiting for Day Rehabilitation Centre (DRC). The second-a structured programme to train and familiarise patients and caregivers to Rebee over patients' Community Hospital (CH) inpatient rehabilitation stay-adopts an evidence-based approach to increase uptake and adherence to Rebee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedNovember 12, 2024
November 1, 2024
11 months
October 29, 2024
November 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Modified Barthel Index scores from baseline to 4, 8, and 12 weeks
Modified Barthel Index (MBI) measures ability to complete activities of daily living (ADLs). Scores range from 0 to 100. A higher score represents more independence, a lower score indicates more assistance needed (ie less independent). 0-20: Total dependence, 21-60: Severe dependence, 61-90: Moderate dependence, 91-99: Slight dependence, 100: Independence.
from recruitment (week 0) till end of study at 12 weeks
Secondary Outcomes (6)
Change in Quality of Life scores from baseline to 4, 8, and 12 weeks
from recruitment (week 0) till end of study at 12 weeks
Change in Patient Activation Level from baseline to 4, 8, and 12 weeks
from recruitment (week 0) till end of study at 12 weeks
Readmission rates to hospital within 30 days of discharge
within 30 days from discharge date
Change in Joint range of motion from baseline to 4, 8, and 12 weeks
from recruitment (week 0) till end of study at 12 weeks
Length of Stay in Community Hospital reported in days
From recruitment (week 0) till end of study at 12 weeks
- +1 more secondary outcomes
Study Arms (2)
Control - usual care
NO INTERVENTIONBusiness as usual in community hospital, no added device intervention
Intervention - Rebee
EXPERIMENTALAddition of Rebee device during and after community hospital stay
Interventions
Tablet device with accompanying sensor device. Tablet device is preloaded with exercises, to be taught to patients during their hospital stay, and to be continued post-discharge
Eligibility Criteria
You may qualify if:
- Rehabilitation Diagnostic Group (RDG): Total Knee Replacement / Deconditioning
- Age 60 and above
- Speak English/Mandarin
- Able to follow instructions, no cognitive impairment
- No MDRO (MultiDrug Resistant Organism)
- Suitable and able to wear motion sensor on upper and lower limbs
- Suitable and able to engage in Rebee exercises
You may not qualify if:
- Not under RDG: Total Knee Replacement / Deconditioning
- Below 60 years old
- Unable to speak English/Mandarin
- Cognitive impaired, unable to follow instructions
- Has MDRO
- Not suitable to wear motion sensor on upper and lower limbs
- Refusal to participate / give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SingHealth Community Hospitalslead
- Rebee Healthcollaborator
- Jurong Community Hospitalcollaborator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- A/Prof
Study Record Dates
First Submitted
October 29, 2024
First Posted
November 12, 2024
Study Start
December 1, 2024
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
November 12, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share